Update on the efficacy of statin treatment in acute coronary syndromes

@article{Rosa2014UpdateOT,
  title={Update on the efficacy of statin treatment in acute coronary syndromes},
  author={Gian Marco Rosa and Federico Carbone and Antonello Parodi and Elena Augusta Massimelli and Claudio Brunelli and François Mach and Nicolas Vuilleumier and Fabrizio Montecucco},
  journal={European Journal of Clinical Investigation},
  year={2014},
  volume={44},
  pages={501 - 515}
}
The natural history of atherosclerosis might involve coronary plaque rupture/erosion, thrombus formation and vessel lumen occlusion, clinically recognized as acute coronary syndrome (ACS). International guidelines strongly recommend early statin administration in patients admitted for ACS. In addition to lowering circulating levels of low‐density lipoprotein cholesterol (LDL‐c), statin treatment was shown to promote plaque stabilization or regression in several ways, including reduction in… Expand
Statins and peripheral arterial disease.
  • A. Markel
  • Medicine
  • International angiology : a journal of the International Union of Angiology
  • 2015
TLDR
As patients with atherosclerosis of the lower limbs have frequently concurrent coronary or cerebrovascular disease, treatment of PAD with statins results in a simultaneous decrease in the incidence of coronary events and stroke. Expand
Statin Induced Dysuria- A Case Report
TLDR
In the present case after re-challenge with similar group of drug patient again developed the symptoms and underlying hyperlipidemia was effectively controlled with Fenofibrates. Expand
Acute Myocardial Infarction Occurring at a Preexisting Intermediate Coronary Artery Stenosis
TLDR
Reports of acute myocardial infarction occurring at a preexisting intermediate coronary stenosis based on invasive coronary angiography performed 10 days before the event are reported. Expand
Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: Results from DYSIS II Europe
TLDR
Elevated blood cholesterol levels are highly prevalent across Europe, with low numbers of coronary patients reaching their recommended LDL-C target, and there is significant scope for intensifying treatment. Expand
PCSK9 inhibitors for treating hypercholesterolemia
TLDR
The purpose of this narrative review is to summarize the current knowledge of PCSK9-i, with particular regard to pharmacodynamic, pharmacokinetic, and clinical data on evolocumab and alirocumab. Expand
Prevalence of lipid abnormalities and cholesterol target value attainment in Egyptian patients presenting with an acute coronary syndrome
  • M. Sobhy, Adel El Etriby, +7 authors A. Gitt
  • Medicine
  • The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology
  • 2018
TLDR
DYSIS II revealed alarming LDL-C goal attainment, with none of the patients with follow-up information available reaching the target of low-density lipoprotein cholesterol <70 mg/dL, either at hospital admission or 4 months after their ACS event. Expand
Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.
TLDR
Few of these very high-risk patients achieved the LDL-C target, indicating huge potential for improving cardiovascular outcome by use of more intensive LLT. Expand
Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients.
TLDR
In spite of statin therapy, LDL-C values were high, with a substantial distance to target that was even more pronounced in (very) high risk patients, and these results call for the optimization of existing treatment strategies and a collaborative effort to improve the impact of treatment guidance on clinical practice. Expand
Low-density lipoprotein cholesterol target achievement in patients surviving an acute coronary syndrome in Hong Kong and Taiwan - findings from the Dyslipidemia International Study II.
TLDR
While LLT was widely employed, statin intensity was low and combination therapy underused, indicating scope for improvement, in patients hospitalized with an ACS, rates of LDL-C target achievement were poor. Expand
A Review on Synthesis and Applications of Statin Family Drugs as a New Generations of Anti-Blood Medicines
TLDR
This work studies the mechanism of the use of statin family drugs and atorvastatin to determine the clinical requirements for improving the dermatology and the statins. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 76 REFERENCES
Association of Statin Therapy with Outcomes of Acute Coronary Syndromes: The GRACE Study
TLDR
Analysis of data from a large, international observational study of acute coronary syndromes identified associations between statin use before and during acute coronary events and favorable outcomes, and examined the effect of early in-hospital statin therapy on important hospital outcomes, including death or the development of recurrent MI or stroke. Expand
Acute effects of statin therapy on coronary atherosclerosis following an acute coronary syndrome.
TLDR
Newly initiated statin therapy is associated with rapid regression of coronary atherosclerosis within 2 months, and this effect was in part associated with decreases in atherogenic lipid and inflammatory parameters. Expand
Statins in acute coronary syndromes: do the guideline recommendations match the evidence?
TLDR
Evidence indicates that early initiation of high-dose statin therapy reduces recurrent ischemia and may reduce revascularization, but does not confer benefit in terms of hard clinical outcomes such as death or myocardial infarction in any of the randomized controlled trials, and may be associated with increased liver and muscle-related adverse outcomes leading to increased withdrawal and suboptimal long-term adherence. Expand
Withdrawal of Statins Increases Event Rates in Patients With Acute Coronary Syndromes
TLDR
Statin pretreatment in patients with acute coronary syndromes is associated with improved clinical outcome, however, discontinuation of statin therapy after onset of symptoms completely abrogates this beneficial effect. Expand
Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: assessment by optical coherence tomography study.
TLDR
The lipid-lowering therapy with statin for 9 months after the onset of acute myocardial infarction significantly increased the fibrous-cap thickness in patients with hyperlipidemia. Expand
Early effect of lipid-lowering therapy with pitavastatin on regression of coronary atherosclerotic plaque. Comparison with atorvastatin.
  • T. Toi, I. Taguchi, +7 authors N. Kaneko
  • Medicine
  • Circulation journal : official journal of the Japanese Circulation Society
  • 2009
TLDR
Fibrofatty composition and plaque volume decreased significantly following treatment with pitavastatin, which suggests that pitavASTatin might have a higher affinity for fibrofat compared with atorvastatin. Expand
Impact of statin therapy on coronary intervention for non-ST elevation acute coronary syndrome with decreased low-density lipoprotein cholesterol.
TLDR
Statin treatment before PCI in patients with non-ST elevation ACS demonstrated beneficial effects such as less myocardial damage, even though both groups presented with low LDL cholesterol levels, however, no significant effect on MACE was seen at 6 months after PCI. Expand
Early Statin Treatment in Patients With Acute Coronary Syndrome: Demonstration of the Beneficial Effect on Atherosclerotic Lesions by Serial Volumetric Intravascular Ultrasound Analysis During Half a Year After Coronary Event: The ESTABLISH Study
TLDR
Early aggressive lipid-lowering therapy by atorvastatin for 6 months significantly reduced the plaque volume in patients with ACS, and Percent change in plaque volume showed a significant positive correlation with percent LDL-C reduction, even in Patients with low baseline cholesterol. Expand
Effect of previous treatment with statins on outcome of patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
TLDR
It is suggested that previous therapy with statins in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PCI) may be associated with reduced short-term mortality. Expand
Statins and cardioprotection--more than just lipid lowering?
TLDR
The cardioprotective effects of statin therapy beyond serum lipid lowering, the underlying mechanisms involved and the potential implications for patients with coronary heart disease are reviewed. Expand
...
1
2
3
4
5
...